Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia

M. Hong Nguyen, Cornelius J. Clancy, Victor L. Yu, Yue C. Yu, Arthur J. Morris, David R. Snydman, Deanna A. Sutton, Michael G. Rinaldi

Research output: Contribution to journalArticle

178 Citations (Scopus)

Abstract

Outcome for 105 patients with candidemia treated with amphotericin B was correlated with amphotericin B in vitro susceptibility results. Thirty-three patients had microbiologic failure, which was defined as persistence of Candida in the bloodstream despite ≤3 days of amphotericin B. Amphotericin B minimum inhibitory concentrations (MICs) were determined by the National Committee for Clinical Laboratory Standards methodology. After determination of MICs, the minimal lethal concentrations (MLCs) were determined. The isolates tested yielded a narrow range of amphotericin B MICs (0.06-2 μg/mL); only 5% (5/105) exhibited MICs ≤1 μg/mL. The MLC range, on the other hand, was significantly broader (0.125 to > 16 μg/mL); 24% (25/105) exhibited MLCs ≤1 μg/mL. The strongest predictor for microbiologic failure was 48-h MLC (P < .001), followed by 24-h MLC (P = .03) and 48-h MIC (P = .11). A resistant break point for amphotericin B of >1 μg/mL for MLC and ≤ 1 μg/mL for MIC could be inferred from this study.

Original languageEnglish (US)
Pages (from-to)425-430
Number of pages6
JournalJournal of Infectious Diseases
Volume177
Issue number2
StatePublished - 1998
Externally publishedYes

Fingerprint

Fungemia
Microbial Sensitivity Tests
Amphotericin B
Candida
Prospective Studies
Candidemia
In Vitro Techniques

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Nguyen, M. H., Clancy, C. J., Yu, V. L., Yu, Y. C., Morris, A. J., Snydman, D. R., ... Rinaldi, M. G. (1998). Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. Journal of Infectious Diseases, 177(2), 425-430.

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. / Nguyen, M. Hong; Clancy, Cornelius J.; Yu, Victor L.; Yu, Yue C.; Morris, Arthur J.; Snydman, David R.; Sutton, Deanna A.; Rinaldi, Michael G.

In: Journal of Infectious Diseases, Vol. 177, No. 2, 1998, p. 425-430.

Research output: Contribution to journalArticle

Nguyen, MH, Clancy, CJ, Yu, VL, Yu, YC, Morris, AJ, Snydman, DR, Sutton, DA & Rinaldi, MG 1998, 'Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia', Journal of Infectious Diseases, vol. 177, no. 2, pp. 425-430.
Nguyen, M. Hong ; Clancy, Cornelius J. ; Yu, Victor L. ; Yu, Yue C. ; Morris, Arthur J. ; Snydman, David R. ; Sutton, Deanna A. ; Rinaldi, Michael G. / Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. In: Journal of Infectious Diseases. 1998 ; Vol. 177, No. 2. pp. 425-430.
@article{2684e757620d4ff89862abbed1bc117d,
title = "Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia",
abstract = "Outcome for 105 patients with candidemia treated with amphotericin B was correlated with amphotericin B in vitro susceptibility results. Thirty-three patients had microbiologic failure, which was defined as persistence of Candida in the bloodstream despite ≤3 days of amphotericin B. Amphotericin B minimum inhibitory concentrations (MICs) were determined by the National Committee for Clinical Laboratory Standards methodology. After determination of MICs, the minimal lethal concentrations (MLCs) were determined. The isolates tested yielded a narrow range of amphotericin B MICs (0.06-2 μg/mL); only 5{\%} (5/105) exhibited MICs ≤1 μg/mL. The MLC range, on the other hand, was significantly broader (0.125 to > 16 μg/mL); 24{\%} (25/105) exhibited MLCs ≤1 μg/mL. The strongest predictor for microbiologic failure was 48-h MLC (P < .001), followed by 24-h MLC (P = .03) and 48-h MIC (P = .11). A resistant break point for amphotericin B of >1 μg/mL for MLC and ≤ 1 μg/mL for MIC could be inferred from this study.",
author = "Nguyen, {M. Hong} and Clancy, {Cornelius J.} and Yu, {Victor L.} and Yu, {Yue C.} and Morris, {Arthur J.} and Snydman, {David R.} and Sutton, {Deanna A.} and Rinaldi, {Michael G.}",
year = "1998",
language = "English (US)",
volume = "177",
pages = "425--430",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia

AU - Nguyen, M. Hong

AU - Clancy, Cornelius J.

AU - Yu, Victor L.

AU - Yu, Yue C.

AU - Morris, Arthur J.

AU - Snydman, David R.

AU - Sutton, Deanna A.

AU - Rinaldi, Michael G.

PY - 1998

Y1 - 1998

N2 - Outcome for 105 patients with candidemia treated with amphotericin B was correlated with amphotericin B in vitro susceptibility results. Thirty-three patients had microbiologic failure, which was defined as persistence of Candida in the bloodstream despite ≤3 days of amphotericin B. Amphotericin B minimum inhibitory concentrations (MICs) were determined by the National Committee for Clinical Laboratory Standards methodology. After determination of MICs, the minimal lethal concentrations (MLCs) were determined. The isolates tested yielded a narrow range of amphotericin B MICs (0.06-2 μg/mL); only 5% (5/105) exhibited MICs ≤1 μg/mL. The MLC range, on the other hand, was significantly broader (0.125 to > 16 μg/mL); 24% (25/105) exhibited MLCs ≤1 μg/mL. The strongest predictor for microbiologic failure was 48-h MLC (P < .001), followed by 24-h MLC (P = .03) and 48-h MIC (P = .11). A resistant break point for amphotericin B of >1 μg/mL for MLC and ≤ 1 μg/mL for MIC could be inferred from this study.

AB - Outcome for 105 patients with candidemia treated with amphotericin B was correlated with amphotericin B in vitro susceptibility results. Thirty-three patients had microbiologic failure, which was defined as persistence of Candida in the bloodstream despite ≤3 days of amphotericin B. Amphotericin B minimum inhibitory concentrations (MICs) were determined by the National Committee for Clinical Laboratory Standards methodology. After determination of MICs, the minimal lethal concentrations (MLCs) were determined. The isolates tested yielded a narrow range of amphotericin B MICs (0.06-2 μg/mL); only 5% (5/105) exhibited MICs ≤1 μg/mL. The MLC range, on the other hand, was significantly broader (0.125 to > 16 μg/mL); 24% (25/105) exhibited MLCs ≤1 μg/mL. The strongest predictor for microbiologic failure was 48-h MLC (P < .001), followed by 24-h MLC (P = .03) and 48-h MIC (P = .11). A resistant break point for amphotericin B of >1 μg/mL for MLC and ≤ 1 μg/mL for MIC could be inferred from this study.

UR - http://www.scopus.com/inward/record.url?scp=0031883309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031883309&partnerID=8YFLogxK

M3 - Article

C2 - 9466531

AN - SCOPUS:0031883309

VL - 177

SP - 425

EP - 430

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 2

ER -